Cellzome is a privately-owned drug discovery company identifying a new generation of kinase targeted drugs to treat inflammatory diseases.
Latest News
• April 2008: TAP Technology Originators nominated for title of European Inventor
of the Year 2008 [+]
• January 2008: Cellzome appoints Dr. Jane Dancer as VP Business Development [+]
• December 2007: Cellzome Establishes Scientific Advisory Board [+]
• November 2007: Cellzome CEO appointed to the Board of the UK's BioIndustryAssociation [+]
• Meet Cellzome at ... [+]